Scandinavian ChemoTech has renewed existing loans from external lenders, larger shareholders and members of the board and CEO
Today ChemoTech signed an extension of the existing credit lines amounting to 6 MSEK, which provides the company with 2 MSEK in unused funds in addition to the existing liquidity of 4 MSEK and excluding the last months orders of 1,7 MSEK.After comparing terms given from several debt finance options, the company has taken these loans to the best market terms available, with an interest rate of 4,5 % per quarter and a setup fee of 5%. “It feels great that ChemoTech can continue to attract debt financing options in today’s financial market, which we see as the best financial option when we